HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

P1 blood group antigen expression and epidemic hemolytic uremic syndrome.

Abstract
P1 blood group positivity has been postulated as a host factor which may provide protection against the development of post-enteropathic hemolytic uremic syndrome (HUS). In this study, blood group status in 20 Inuit survivors of Escherichia coli O157:H7-associated HUS was compared with age- and sex-matched controls from the same community who had experienced uncomplicated diarrheal illness due to the same pathogen. Of 20 HUS survivors, 6 were P1 antigen positive compared with 8 of the 20 controls (P = 0.7). We conclude that P1 antigen positivity was not protective against HUS in this population. Further studies of this condition to clarify the role of host factors in verotoxin-induced endothelial damage are indicated.
AuthorsP H Orr, V Dong, M L Schroeder, M R Ogborn
JournalPediatric nephrology (Berlin, Germany) (Pediatr Nephrol) Vol. 9 Issue 5 Pg. 612-3 (Oct 1995) ISSN: 0931-041X [Print] Germany
PMID8580022 (Publication Type: Journal Article)
Chemical References
  • Antigens, Nuclear
  • Autoantigens
  • Bacterial Toxins
  • Enterotoxins
  • Nuclear Proteins
  • Shiga Toxin 1
Topics
  • Aged
  • Antigens, Nuclear
  • Autoantigens (blood)
  • Bacterial Toxins (blood)
  • Canada (epidemiology)
  • Case-Control Studies
  • Child
  • Child, Preschool
  • Disease Outbreaks
  • Enterotoxins (blood)
  • Escherichia coli
  • Female
  • Follow-Up Studies
  • Gastroenteritis (complications, epidemiology, immunology, microbiology)
  • Hemolytic-Uremic Syndrome (epidemiology, immunology, microbiology)
  • Humans
  • Infant
  • Male
  • Nuclear Proteins (blood)
  • Shiga Toxin 1

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: